Arix Bioscience (ARIX.L) stock price, revenue, and financials

Arix Bioscience market cap is £117.3 m, and annual revenue was £1.33 m in FY 2018

£117.3 M

ARIX.L Mkt cap, 26-Jun-2020

£1.3 M

Arix Bioscience Revenue FY, 2018
Arix Bioscience Net income (FY, 2018)36.9 M
Arix Bioscience EBIT (FY, 2018)40.8 M
Arix Bioscience Cash, 31-Dec-201891.2 M
Arix Bioscience EV26 M

Arix Bioscience Income Statement

Annual

GBPFY, 2017FY, 2018

Revenue

1.9m1.3m

Depreciation and amortization

218.0k216.0k

EBIT

(3.6m)40.8m

EBIT margin, %

(193%)3073%

Interest expense

16.0k12.0k

Interest income

1.0k720.0k

Pre tax profit

(7.7m)42.8m

Income tax expense

(221.0k)5.9m

Net Income

(7.5m)36.9m

Arix Bioscience Balance Sheet

Annual

GBPFY, 2017FY, 2018

Cash

74.9m91.2m

Accounts Receivable

275.0k1.7m

Current Assets

76.2m93.4m

PP&E

523.0k313.0k

Total Assets

150.1m279.5m

Accounts Payable

544.0k228.0k

Current Liabilities

3.7m9.3m

Total Liabilities

3.7m9.3m

Common Stock

105.1m188.6m

Retained Earnings

42.1m82.0m

Total Equity

146.4m270.2m

Financial Leverage

1 x1 x

Arix Bioscience Cash Flow

Annual

GBPFY, 2017FY, 2018

Cash From Operating Activities

(8.8m)(11.1m)

Cash From Investing Activities

(50.2m)(115.4m)

Cash From Financing Activities

105.1m82.2m

Net Change in Cash

46.0m(44.2m)

Arix Bioscience Ratios

GBPFY, 2017

Revenue/Employee

137.6k

Financial Leverage

1 x